Recurrent hypoglycemia exacerbates cerebral ischemic damage in streptozotocin-induced diabetic rats

Stroke

Volumn 42, Issue 5, 2011, Pages 1404-1411

  Dave, Kunjan R ^a   Tamariz, John ^a   Desai, Kushal M ^a   Brand, Frank J ^a   Liu, Annie ^a   Saul, Isabel ^a   Bhattacharya, Sanjoy K ^b   Pileggi, Antonello ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

brain ischemia; cardiac arrest; diabetes; free radicals; glucose; mitochondria; stroke

Indexed keywords

FREE RADICAL; GLUCOSE; INSULIN; LINPLANT; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE EXACERBATION; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; HYPOGLYCEMIA; INSULIN TREATMENT; MALE; MITOCHONDRION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENT DISEASE; STREPTOZOCIN DIABETES;

ANIMALS; BRAIN ISCHEMIA; CA1 REGION, HIPPOCAMPAL; CELL DEATH; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FREE RADICALS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MITOCHONDRIA; NEURONS; RATS; RATS, WISTAR; RECURRENCE; RISK FACTORS; STREPTOZOCIN;

EID: 79955468734     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.594937     Document Type: Article

References (47)

1. Diabetes Statistics. American Diabetes Association. www.diabetes.org/ diabetes-basics/diabetes-statistics/. Accessed March 9, 2010
2. Stroke. American Diabetes Association. www.diabetes.org/living-with- diabetes/complications/stroke.html. Accessed March 9, 2010.
3. Biller J, Love BB. Diabetes and stroke. Med Clin North Am. 1993;77: 95-110. (Pubitemid 23066799)
4. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979; 2:120-126. (Pubitemid 9238733)
5. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. Diabetologia. 1978;14:363-370. (Pubitemid 8357140)
6. Jorgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen stroke study. Stroke. 1994;25:1977-1984. (Pubitemid 24291283)
7. Auer RN. Insulin, blood glucose levels, and ischemic brain damage. Neurology. 1998;51:S39-S43. (Pubitemid 28429323)
8. Martini SR, Kent TA. Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab. 2007;27:435-451.
9. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med. 1983;74:540-544 (Pubitemid 13125970)
10. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial research group. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-986.
11. Leese GP, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W, Frier BM, Morris AD. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care. 2003;26:1176-1180. (Pubitemid 36929268)
12. The effect of intensive diabetes therapy on the development and pro-gression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med. 1995;122:561-568.
13. Cryer PE. Hypoglycemia in diabetes: pathophysiological mechanisms and diurnal variation. Prog Brain Res. 2006;153:361-365. (Pubitemid 44107426)
14. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care. 2001;24: 1858-1862. (Pubitemid 33716491)
15. Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359: 1464-1476.
16. Dave KR, Pileggi A, Saul I, Perez-Pinzon MA. Chronic intermittent mild hypoglycemic episodes exacerbate ischemic damage in streptozotocin-induced diabetic rats. Stroke. 2008;39:50.
17. Inouye KE, Yue JT, Chan O, Kim T, Akirav EM, Park E, Riddell MC, Burdett E, Matthews SG, Vranic M. Effects of insulin treatment without and with recurrent hypoglycemia on hypoglycemic counterregulation and adrenal catecholamine-synthesizing enzymes in diabetic rats. Endocrinology. 2006; 147:1860-1870.
18. McCrimmon RJ, Fan X, Cheng H, McNay E, Chan O, Shaw M, Ding Y, Zhu W, Sherwin RS. Activation of amp-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. Diabetes. 2006;55: 1755-1760. (Pubitemid 44324129)
19. Dave KR, Lange-Asschenfeldt C, Raval AP, Prado R, Busto R, Saul I, Perez-Pinzon MA. Ischemic preconditioning ameliorates excitotoxicity by shifting glutamate/gamma-aminobutyric acid release and biosynthesis. J Neurosci Res. 2005;82:665-673. (Pubitemid 41740467)
20. Lee CP, Sciamanna M, Peterson PL. Intact rat brain mitochondria from a single animal: preparation and properties. Methods Toxicol. 1993;2: 41-50.
21. Dave KR, DeFazio RA, Raval AP, Torraco A, Saul I, Barrientos A, Perez-Pinzon MA. Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase C epsilon. JNeurosci. 2008;28: 4172-4182.
22. Dave KR, Saul I, Busto R, Ginsberg MD, Sick TJ, Perez-Pinzon MA. Ischemic preconditioning preserves mitochondrial function after global cerebral ischemia in rat hippocampus. J Cereb Blood Flow Metab. 2001; 21:1401-1410. (Pubitemid 33117180)
23. Culnan DM, Cooney RN, Stanley B, Lynch CJ. Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass. Obesity (Silver Spring). 2009;17:46-52. (Pubitemid 50310534)
24. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, Keating SP, Hunter CL, Nuwaysir LM, Schaeffer DA. The paragon algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics. 2007;6:1638-1655. (Pubitemid 47506173)
25. McGowan JE, Chen L, Gao D, Trush M, Wei C. Increased mitochondrial reactive oxygen species production in newborn brain during hypo-glycemia. Neurosci Lett. 2006;399:111-114.
26. Kauppinen RA, Nicholls DG. Synaptosomal bioenergetics. The role of glycolysis, pyruvate oxidation and responses to hypoglycaemia. Eur J Biochem. 1986;158:159-165. (Pubitemid 16066517)
27. Brand MD. The sites and topology of mitochondrial superoxide produc-tion. Exp Gerontol. 2010;45:466-472.
28. Lazarou M, Thorburn DR, Ryan MT, McKenzie M. Assembly of mito-chondrial complex I and defects in disease. Biochim Biophys Acta. 2009; 1793:78-88
29. EDIC. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemi-ology ofDiabetes Interventions and Complications (EDIC) study. JAMA. 2003;290:2159-2167.
30. McCrimmon R. The mechanisms that underlie glucose sensing during hypoglycaemia in diabetes. Diabet Med. 2008;25:513-522. (Pubitemid 351590875)
31. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypo-glycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest. 1993;91:819-828. (Pubitemid 23095255)
32. Kinsley BT, Simonson DC. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1996;81:684-691. (Pubitemid 26055685)
33. Hoffman WE, Pelligrino D, Werner C, Kochs E, Albrecht RF, Schulteam Esch J. Ketamine decreases plasma catecholamines and improves outcome from incomplete cerebral ischemia in rats. Anesthesiology. 1992; 76:755-762.
34. Krugers HJ, Maslam S, Korf J, Joels M, Holsboer F. The corticosterone synthesis inhibitor metyrapone prevents hypoxia/ischemia-induced loss of synaptic function in the rat hippocampus. Stroke. 2000;31:1162-1172. (Pubitemid 30253541)
35. Krugers HJ, Maslam S, Van Vuuren SM, Korf J, Joels M. Postischemic steroid modulation: effects on hippocampal neuronal integrity and synaptic plasticity. J Cereb Blood Flow Metab. 1999;19:1072-1082. (Pubitemid 30167757)
36. Schultz JA, Hoffman WE, Albrecht RF. Sympathetic stimulation with physostigmine worsens outcome from incomplete brain ischemia in rats. Anesthesiology. 1993;79:114-121. (Pubitemid 23215156)
37. Wright G, Terada K, Yano M, Sergeev I, Mori M. Oxidative stress inhibits the mitochondrial import of preproteins and leads to their degra-dation. Exp Cell Res. 2001;263:107-117. (Pubitemid 32989111)
38. Mokranjac D, Neupert W. Protein import into isolated mitochondria. Methods Mol Biol. 2007;372:277-286.
39. Cortes-Rojo C, Calderon-Cortes E, Clemente-Guerrero M, Estrada-Villagomez M, Manzo-Avalos S, Mejia-Zepeda R, Boldogh I, Saavedra-Molina A. Elucidation of the effects of lipoperoxidation on the mito-chondrial electron transport chain using yeast mitochondria with manipulated fatty acid content. J Bioenerg Biomembr. 2009;41:15-28.
40. Camp AJ, Wijesinghe R. Calretinin: modulator of neuronal excitability. Int J Biochem Cell Biol. 2009;41:2118-2121.
41. Mojumder DK, Wensel TG, Frishman LJ. Subcellular compartmental-ization of two calcium binding proteins, calretinin and calbindin-28 kDa, in ganglion and amacrine cells of the rat retina. Mol Vis. 2008;14: 1600-1613.
42. Hubbard MJ, McHugh NJ. Calbindin28kDa and calbindin30kDa (cal-retinin) are substantially localised in the particulate fraction of rat brain. FEBS Lett. 1995;374:333-337.
43. Saraswathy S, Rao NA. Mitochondrial proteomics in experimental auto-immune uveitis oxidative stress. Invest Ophthalmol Vis Sci. 2009;50: 5559-5566.
44. Peng TI, Jou MJ. Oxidative stress caused by mitochondrial calcium overload. Ann N Y Acad Sci. 1201:183-188.
45. Mallard EC, Williams CE, Gunn AJ, Gunning MI, Gluckman PD. Frequent episodes of brief ischemia sensitize the fetal sheep brain to neuronal loss and induce striatal injury. Pediatr Res. 1993;33:61-65. (Pubitemid 23094128)
46. Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmo-lality. Am J Physiol Heart Circ Physiol. 2000;278:H1218-H1224. (Pubitemid 30235499)
47. Puente EC, Silverstein J, Bree AJ, Musikantow DR, Wozniak DF, Maloney S, Daphna-Iken D, Fisher SJ. Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia. Diabetes. 2010;59:1055-1062